EUVIMEDSkopri EUVIMED
Open access

Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study

Entscheidungsunterstützungssystem zur Früherkennung von Pankreaskrebs in der Primärversorgung: Simulationsstudie

Javiera Martinez-Gutierrez iD, Kaleswari Somasundaram iD, Christina Maresch Bernardes iD, Meena Rafiq iD, Silja Schrader iD, Susan Jordan iD, Sophie Chima iD, Lucas De Mendonca iD, Kit Huckvale iD, Barbara Hunter iD, Jo-Anne Manski-Nankervis iD, James Lawson iD and 4 more

JMIR Formative Research · 2026-02-06 · 10 · e79209

DOI: 10.2196/79209 ↗

Auf einen Blick

In einer Simulationsumgebung fanden Hausärzt:innen ein CDSS zur Früherkennung von Pankreaskrebs praktikabel und nützlich. Genannt wurden aber Bedenken zu Überdiagnostik, Kosten und Patient:innenangst.

Fragestellung

Wie akzeptabel und machbar ist ein CDSS zur Identifikation von Patient:innen mit Symptomen eines Pankreaskarzinoms in der Primärversorgung?

Methode

CDSS mit elektronischer Patientenakte in einer Simulationslaborumgebung; 11 Hausärzt:innen; Interviews und thematische Analyse mit 2 Frameworks.

Ergebnisse

11 Hausärzt:innen bewerteten das CDSS als leicht nutzbar, unaufdringlich und als hilfreichen Hinweis für weitere Abklärungen. Genannt wurden Bedenken zu Übertestung, finanziellen Kosten und Angst bei Patient:innen.

Einschränkungen

Nur Simulationsumgebung; qualitative Auswertung; kleine Zahl von 11 Hausärzt:innen.

Schlussfolgerung der Autor:innen

Das Tool war insgesamt akzeptabel und mit dem Arbeitsablauf vereinbar, aber zusätzliche Evidenz ist nötig, bevor ein CDSS mit diesen Empfehlungen in der Primärversorgung umgesetzt wird.

Kernaussagen

  • CDSS wurde von Hausärzt:innen als leicht nutzbar beschrieben
  • Bedenken zu Übertestung, Kosten und Patient:innenangst
  • Weitere Evidenz vor Umsetzung in der Primärversorgung gefordert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in JMIR Formative Research, published online on 2026-02-06. Written by Javiera Martinez-Gutierrez and 15 co-authors. Institution: Department of General Practice, Medicine, Dentristry and Health Services, The University of Melbourne, Melbourne, Australia. Major MEDLINE topics: Pancreatic Neoplasms, Decision Support Systems, Clinical, Early Detection of Cancer. Cited 2 times so far (Crossref); 59 references. The full text is freely available in PubMed Central. Funded by: National Health and Medical Research Council.

Auf einen BlickAstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Early detection in primary care could improve pancreatic cancer survival, but diagnosis is often delayed due to the low prevalence of the disease, the nonspecific nature of early symptoms, and the broad range of conditions and volume of consultations managed by general practitioners (GPs). In Australia, improving pancreatic cancer outcomes, including via earlier diagnosis, is a priority being progressed under the National Pancreatic Cancer Roadmap developed by Cancer Australia. Computerized clinical decision support systems (CDSSs) have shown promise in aiding timely cancer diagnosis; however, barriers to adopting CDSS such as mistrust of the recommendations or not being embedded in the clinical workflow remain. Simulation techniques, which offer flexible and cost-effective ways to evaluate digital health interventions, can be used to test CDSS before real-world implementation.

Objective

This study aims to assess the acceptability and feasibility of identifying patients with symptoms associated with pancreatic cancer through a CDSS within a simulated environment.

Methods

We developed a CDSS that interacted with an electronic health record used in general practice to identify patients with symptoms, which may indicate pancreatic cancer (unintended weight loss or new-onset diabetes), in a simulation laboratory for digital interventions. We tested it by inviting GPs (n=11) to use the CDSS, with patient actors simulating specific clinical scenarios. We then interviewed GPs about the interaction to assess the acceptability and feasibility of the CDSS in their clinical practice. We used thematic analysis and 2 relevant frameworks to analyze the data.

Results

GPs found the CDSS easy to use, unobstructive, and effective as a prompt to consider investigations for people with risk factors for pancreatic cancer. However, they expressed concerns about possible overtesting, financial costs, and the potential for anxiety in patients with a very low probability of having cancer.

Conclusions

While GPs found the tool useful and compatible with their workflow, concerns about overtesting, lack of evidence, and cost-effectiveness were identified as barriers. GPs favored a stepwise approach to investigations rather than immediate imaging. Despite the overall acceptability of the tool, additional evidence to underpin clinical recommendations is necessary before implementing a CDSS with these specific recommendations for pancreatic cancer in primary care.

Subjects

MeSH terms (MEDLINE)

Pancreatic NeoplasmsDecision Support Systems, ClinicalEarly Detection of CancerHumansPrimary Health CareAustraliaFemaleMaleMiddle AgedAgedAdultComputer Simulation

Author keywords

cancerclinical decision supportdigital healthearly detectiongeneral practicesimulation

Authors and institutions

  • Department of General Practice, Medicine, Dentristry and Health Services, The University of Melbourne, Melbourne, Australia.
  • Collaborative Centre for Genomic Cancer Medicine, The University of Melbourne, Melbourne, Australia.
  • Department of Family Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • School of Public Health, The University of Queensland, Brisbane, Australia.
  • Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Data Connect, Victorian Comprehensive Cancer Centre, Melbourne, Australia.

ORCID profiles: Javiera Martinez-Gutierrez, Kaleswari Somasundaram, Christina Maresch Bernardes, Meena Rafiq, Silja Schrader, Susan Jordan, Sophie Chima, Lucas De Mendonca, Kit Huckvale, Barbara Hunter, Jo-Anne Manski-Nankervis, James Lawson, Katrina Anderson, Vivienne Milch, Rachel E Neale, Jon Emery

Funding

  • National Health and Medical Research Council

Cite

APA

Martinez-Gutierrez, J., Somasundaram, K., Bernardes, C. M., Rafiq, M., Schrader, S., Jordan, S., Chima, S., De Mendonca, L., Huckvale, K., Hunter, B., Manski-Nankervis, J. A., Lawson, J., Anderson, K., Milch, V., Neale, R. E., & Emery, J. (2026). Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study. JMIR Formative Research, 10, e79209. https://doi.org/10.2196/79209

Vancouver

Martinez-Gutierrez J, Somasundaram K, Bernardes CM, Rafiq M, Schrader S, Jordan S, et al. Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study. JMIR Formative Research. 2026;10:e79209. doi:10.2196/79209

BibTeX
@article{MartinezGutierrez2026,
  author = {Martinez-Gutierrez, Javiera and Somasundaram, Kaleswari and Bernardes, Christina Maresch and Rafiq, Meena and Schrader, Silja and Jordan, Susan and Chima, Sophie and De Mendonca, Lucas and Huckvale, Kit and Hunter, Barbara and Manski-Nankervis, Jo-Anne and Lawson, James and Anderson, Katrina and Milch, Vivienne and Neale, Rachel E and Emery, Jon},
  title = {Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study},
  journal = {JMIR Formative Research},
  year = {2026},
  volume = {10},
  pages = {e79209},
  doi = {10.2196/79209}
}
Start for free →